Core Insights - The digital healthcare industry is experiencing robust growth driven by technological innovations and capital investments, particularly in artificial intelligence and brain-computer interface sectors [1][3] Policy Developments - The digital healthcare sector is heavily influenced by government policies, which have been systematically promoting the application and development of emerging technologies like AI and brain-computer interfaces through various measures [3][4] - In 2025, significant policies were introduced to enhance the integration of AI in healthcare, focusing on practical applications and regulatory innovation [3][4] - Brain-computer interfaces have been elevated to a national strategic level, with several milestone policies established to support their development [4][5] Product Innovations - The digital healthcare sector has seen a surge in AI model products, with a notable increase in the number of approved AI medical devices, reaching 207 by December 2025 [11] - AI applications are expanding beyond diagnostic tools to include treatment planning and clinical management, indicating a shift towards integrated healthcare solutions [11][12] - The emergence of specialized AI models for various medical fields, such as oncology and chronic disease management, showcases the sector's innovation and adaptability [8][10] Capital Market Activity - The financing landscape for AI and brain-computer interface sectors has been vibrant, with record-breaking funding rounds, including a notable 1 billion yuan investment in a digital healthcare company [18][19] - The IPO market for AI healthcare companies is gaining momentum, reflecting strong investor interest and the potential for growth in this sector [18][19] Data Utilization - The healthcare industry is advancing towards data assetization, with policies facilitating the efficient sharing and utilization of medical data [15][16] - The second use of medical data is becoming more prevalent, with AI technologies being integrated into various operational and clinical processes [16][17] Market Trends - The focus of digital marketing in healthcare is shifting towards patient-centered services, driven by policy changes and increasing patient awareness [17] - The brain-computer interface sector is witnessing a surge in clinical trials and technological advancements, positioning it as a key area for future growth [14][15]

Group 1 - Yuanxin Technology has achieved systematic breakthroughs in three major areas of medical insurance, successfully connecting in-hospital patient services, out-of-hospital patient management, and health protection, benefiting over one million patients [1] - The "Yuanquan Partner Intelligent Agent Cluster" developed by Yuanxin Pharmacy has established a comprehensive out-of-hospital intelligent patient management system, enhancing the management capacity of pharmacists from 200 patients to a more efficient model [1] - The system utilizes an automated follow-up mechanism that sends medication guidance, disease knowledge, and refill reminders, creating personalized patient profiles for targeted service delivery [1][2] Group 2 - Significant results have been observed in patient management projects, with the medication cycle for a first-line Her-2 positive drug extending from 7.6 months to 7.9 months, and a 7.6% increase in PD-1 drug refill rates [2] - The system has managed over one million special drug patients, with more than 9 million patient interactions, achieving a 100% coverage rate for standardized special drug service processes [2] - Yuanxin Medical has launched a full-process task-based interaction system that integrates 11 functions, allowing patients to describe their needs via mobile, thus creating a closed-loop service experience [2] Group 3 - The multi-agent platform architecture serves as the core engine for efficient service, with a central coordinator linking various modules in real-time, ensuring local data processing and rapid response times [3] - Yuanxin Technology is transforming health insurance services from a "single policy" model to a "lifetime health service" model, addressing common user pain points such as slow response times and complex claims processes [3] - The AI customer manager developed by Yuanxin Huibao has achieved a 95% problem resolution rate, significantly improving efficiency compared to traditional methods [3] Group 4 - The integration of medical, pharmaceutical, and insurance services by Yuanxin Huibao creates a closed loop of "health prevention - diagnostic support - cost protection," shifting the essence of insurance from post-event compensation to proactive management [4]